Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

300357.SZ Gross Margin

The Gross Margin of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357.SZ) is 95.16%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

300357.SZ Gross Margin - Historical Value
Date Value
2024-12-31 95.16%
2023-12-31 95.26%
2022-12-31 95.39%
2021-12-31 95.74%
2020-12-31 95.52%
2019-12-31 96.42%
2018-12-31 94.31%
2017-12-31 96.34%
2016-12-31 96.28%
2015-12-31 95.10%
300357.SZ Gross Margin - Peers Comparison
Ticker Name Value
002019.SZ Yifan Pharmaceutical Co Ltd 46.79%
002099.SZ Zhejiang Hisoar Pharmaceutical Co Ltd 18.31%
002294.SZ Shenzhen Salubris Pharmaceuticals Co Ltd 71.63%
300702.SZ Zhejiang Tianyu Pharmaceutical Co Ltd 33.06%
603718.SS Shanghai Hile Bio-Technology Co Ltd 58.50%
300363.SZ Porton Pharma Solutions Ltd 23.33%
603520.SS Zhejiang Starry Pharmaceutical Co Ltd 23.12%
000423.SZ Dong-E-E-Jiao Co Ltd 72.57%
000623.SZ Jilin Aodong Pharmaceutical Group Co Ltd 38.62%
600521.SS Zhejiang Huahai Pharmaceutical Co Ltd 60.64%
688526.SS Wuhan Keqian Biology Co Ltd 62.40%
002626.SZ Xiamen Kingdomway Group Co 38.33%
300119.SZ Tianjin Ringpu Bio-Technology Co Ltd 40.73%
002773.SZ Chengdu Kanghong Pharmaceutical Group Co Ltd 89.46%
300558.SZ Betta Pharmaceuticals Co Ltd 81.38%
600867.SS Tonghua Dongbao Pharmaceutical Co Ltd 72.75%
688505.SS Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 91.05%
002287.SZ Tibet Cheezheng Tibetan Medicine Co Ltd 82.05%
002399.SZ Shenzhen Hepalink Pharmaceutical Group Co Ltd 33.10%
002653.SZ Haisco Pharmaceutical Group Co Ltd 71.47%
2096.HK Simcere Pharmaceutical Group Ltd 80.25%
603456.SS Zhejiang Jiuzhou Pharmaceutical Co Ltd 30.89%
603707.SS Nanjing King-friend Biochemical Pharmaceutical Co Ltd 46.17%
002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd 46.47%
1477.HK Ocumension Therapeutics 53.93%
300630.SZ Hainan Poly Pharm Co Ltd 72.65%
460.HK Sihuan Pharmaceutical Holdings Group Ltd 65.32%
688321.SS Shenzhen Chipscreen Biosciences Co Ltd 86.71%